Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MSON

Misonix (MSON) Stock Price, News & Analysis

Misonix logo

About Misonix Stock (NASDAQ:MSON)

Advanced Chart

Key Stats

Today's Range
$26.54
$26.54
50-Day Range
$24.89
$26.54
52-Week Range
$11.04
$26.99
Volume
2 shs
Average Volume
60,302 shs
Market Capitalization
$462.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.

Receive MSON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter.

MSON Stock News Headlines

AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

MSON Stock Analysis - Frequently Asked Questions

Misonix, Inc. (NASDAQ:MSON) announced its earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider had revenue of $19.69 million for the quarter. Misonix had a negative trailing twelve-month return on equity of 10.36% and a negative net margin of 19.55%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Misonix investors own include Edap Tms (EDAP), Canopy Growth (CGC), Varian Medical Systems (VAR), Fulgent Genetics (FLGT), Ampio Pharmaceuticals (AMPE), Sociedad Química y Minera de Chile (SQM) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
9/02/2021
Today
5/31/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Laboratory Apparatus & Furniture
Sub-Industry
N/A
Current Symbol
NASDAQ:MSON
Employees
254
Year Founded
1959

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.47 million
Pretax Margin
-19.37%

Debt

Sales & Book Value

Annual Sales
$74.02 million
Price / Cash Flow
N/A
Book Value
$7.77 per share
Price / Book
3.42

Miscellaneous

Free Float
11,893,000
Market Cap
$462.06 million
Optionable
Not Optionable
Beta
1.36

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:MSON) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners